DeepScan Diagnostics

Company Description

DeepScan Diagnostics is revolutionizing veterinary care with the world’s most advanced cancer and health screening test for dogs. Powered by cfDNA technology, this test detects cancer and chronic conditions earlier than ever before, offering veterinarians comprehensive diagnostics that enhance traditional CRP testing for inflammation and illness monitoring. With unmatched accuracy, DeepScan’s mission is to make this test a routine part of every blood panel drawn from dogs, transforming veterinary diagnostics. Now, DeepScan is actively seeking distribution partners to bring this breakthrough test to veterinary clinics worldwide. The company has already secured a major distribution pilot in Europe. The team of world-class scientists and serial entrepreneurs is also developing a PCR-based follow-up test to provide additional insights into elevated cfDNA levels, and next year, the test will be available as a point-of-care solution. The company is still in stealth mode and will be publicly launched in November 2024.